Form 4: AbbVie Executive Jeffrey R. Stewart Reports Stock Transactions

EVP and Chief Commercial Officer of AbbVie, Jeffrey R. Stewart, reports the exercise of stock options and subsequent sale of shares on March 31, 2025.

Summary

• On March 31, 2025, Jeffrey R. Stewart, EVP and Chief Commercial Officer of AbbVie Inc., exercised stock options for 25,700 shares at a price of $79.02 per share.
• Following the exercise of these options, Stewart sold 25,700 shares at a weighted average price of $209.49 and 33,132 shares at a weighted average price of $210.54.
• After these transactions, Stewart directly owns 53,234 shares of AbbVie common stock and indirectly owns 1,338 shares through a spouse's trust.
• The reported transactions were executed pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program.

Sentiment

Score: 5

Explanation: This is a neutral reporting of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company executives as it can provide insights into their confidence in the company's future prospects.

Key Dates

Keywords

AbbVie, ABBV, Jeffrey R. Stewart, Stock Options, Form 4, Executive Compensation, Insider Trading, Securities Exchange Act, Stock Sale